Canadian Diabetes Risk Assessment Questionnaire (CANRISK)

ورودی‌های بالینی بیمار

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
canrisk score
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Low Risk0–20
  • Moderate Risk21–32
  • High Risk33–86
Direct Clinical Answer

The Canadian Diabetes Risk Assessment Questionnaire (CANRISK) calculates evaluating glycemic control, metabolic decompensation severity, and long-term endocrine risks. Key inputs include age. Scores guide titrating insulin infusion protocols, managing fluid-electrolyte resuscitation, and long-term risk reduction. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

CANRISK screens for undiagnosed type 2 diabetes mellitus and prediabetes in Canadian adults aged 18-74 years. It was developed by the Canadian Task Force on Preventive Health Care in partnership with the Public Health Agency of Canada and has been validated in Canada's multi-ethnic population.

Clinical Indication

The Canadian Diabetes Risk Assessment Questionnaire (CANRISK) is indicated for bedside clinical practice to support CANRISK screens for undiagnosed type 2 diabetes mellitus and prediabetes in Canadian adults aged 18-74 years. It was developed by the Canadian Task Force on Preventive Health Care in partnership with the Public Health Agency of Canada and has been validated in Canada's multi-ethnic population.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with diabetes mellitus, diabetic ketoacidosis (DKA), hyperosmolar hyperglycemic state, thyroid storm, or adrenal crisis. Clinical application is indicated across Endocrinology clinics, inpatient metabolic services, and acute diabetes care units.

Limitations & Contraindications

Severe hyperglycemia lowers measured serum sodium; corrected sodium equations must guide intravenous fluid selection.

Clinical Pearls & Action Plan

Serial monitoring of serum electrolytes, potassium kinetics, venous pH, and anion gap is mandatory during acute metabolic crisis management.

Formula & Variables:

Sum of points from: age (0-15) + gender (0-6) + BMI (0-14) + waist circumference (0-6) + physical activity (0-1) + diet (0-2) + blood pressure (0-4) + blood sugar (0-14) + large baby (0-1) + family history (0-8) + ethnicity (0-11)

Input Parameters

NameTypeRequiredDescription
agestringYesAge range of the patient
genderstringYesBiological sex of the patient
bmistringYesBody Mass Index (kg/m²) category
waist_circumferencestringYesWaist circumference measured at belly button level
physical_activitystringYesDo you do at least 30 minutes of physical activity every day? (e.g., brisk walking, gardening, cleaning, etc.)
vegetable_fruit_consumptionstringYesHow often do you eat vegetables or fruits?
high_blood_pressurestringYesHave you ever been told by a doctor or nurse that you have high blood pressure OR have you ever taken high blood pressure medication?
high_blood_sugarstringYesHave you ever been found to have high blood sugar? (e.g., in a health examination, during an illness, during pregnancy)
large_babystringYesHave you ever given birth to a large baby weighing 4 kg (9 lbs) or more? (Females only)
family_diabetesstringYesDo you have a mother, father, sister, or brother with diabetes?
ethnicitystringYesWhat ethnic group does your biological (blood) mother and/or father belong to? If more than one group applies, choose the one with the highest score

Score Interpretation & Guidance

RangeStageDescription
0–20Low RiskLow risk of type 2 diabetes
21–32Moderate RiskModerate risk of type 2 diabetes
33–86High RiskHigh risk of type 2 diabetes

Evidence-Based References (EBM)

  • Robinson CA, Agarwal G, Nerenberg K. Validating the CANRISK prognostic model for assessing diabetes risk in Canada's multi-ethnic population. Chronic Dis Inj Can. 2011 Dec;32(1):19-31. PMID: 22153173.PMID: 22153173
  • Public Health Agency of Canada. CANRISK: The Canadian Diabetes Risk Questionnaire User Guide for Pharmacists. Ottawa: Public Health Agency of Canada; 2011.
  • Anand SS, Samaan Z, Middleton C, Irvine J, Desai D, Schulze KM, et al. A digital health intervention to lower cardiovascular risk: a randomized clinical trial. JAMA Cardiol. 2016 Aug 1;1(5):601-6. doi: 10.1001/jamacardio.2016.1035.DOI: 10.1001/jamacardio.2016.1035

Related calculators